Technologies

Pharmaceutical Sciences

Title:

Enzyme-based Cholesterol-lowering Probiotic Complex

Area:

Pharmaceutical Sciences

Focus Area:

Probiotics, cholesterol management

Status:

Commercialised

Patent:

Yes

Company Transferred:

Yes

Developing Agency:

CSIR-NCL, Pune

Technology Readiness Label:

Not specified

Budget:

Not specified

Funding Agency:

CSIR- Council of Scientific & Industrial Research

Lead Developer:

Abhiruchi Probiotics Pvt. Ltd.

Source Title:

Startups Book 2024
Source (more info) :https://www.csir.res.in/sites/default/files/2024-12/startups_book_2024.pdf

Brief Description

Description :

Probiotic isolate APS strain of Brevibacterium for cholesterol reduction; exclusive license from CSIR-NCL; Eureka award winner; pre-clinical trials complete

Related Technologies